CPT code 81215: BRCA1 testing, known familial variant2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Targeted BRCA1 testing checks for a specific inherited variant already identified in a family during hereditary cancer risk evaluation.
Medicare pays $375.25 for 81215 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$375.25
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 81215 covers
BRCA1 known familial variant testing examines a patient’s germline DNA for a specific BRCA1 change already identified in a relative. It supports cascade testing in families with hereditary breast and ovarian cancer risk, helping determine whether the tested relative inherited that variant. Clinical molecular laboratories perform the analysis, commonly using a blood specimen; oncologists and other clinicians may order it as part of inherited-cancer risk evaluation.
Report this code for analysis directed at the known familial BRCA1 variant, rather than broad BRCA1 sequencing. Medicare pays the test under the CLFS, with one national amount per code and no locality or office-versus-facility adjustment. The 2026 national CLFS amount is $375.25, unchanged since 2020. The code is paid only through the CLFS, not the physician fee schedule.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 81215
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 81215. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 81215 with status X (excluded by statute), so the test itself is paid only from the CLFS.
81215 on the lab fee schedule since 2020
81215 · CLFS 2026 Q4 (current)
$375.25
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
81215 compared with similar tests
- 81212BRCA testingThree specified variants$440.00
- This code targets a known familial BRCA1 variant. Code 81212 is for specified BRCA1 and BRCA2 founder variants.
- 81216BRCA2 sequencingFull gene sequence$185.12
- Code 81216 analyzes BRCA2 across the gene; 81215 targets a known familial variant in BRCA1.
- 81217BRCA2 testingKnown familial variant$375.25
- Both codes target a known familial variant, but 81217 is for BRCA2 and 81215 is for BRCA1.
81215 billing questions
When should this code be used instead of broader BRCA1 testing?
Use it when a specific BRCA1 variant has already been identified in the family and testing is directed at that variant. Broader analysis is a different scope of testing.
Does this code represent full BRCA1 sequencing?
No. It represents targeted analysis for a known familial BRCA1 variant, not full-gene sequencing.
What should the record support?
Document the hereditary cancer risk evaluation and the specific familial BRCA1 variant being investigated.
How does Medicare pay for this test?
Medicare pays it through the CLFS at one national amount for the code, without geographic or office-versus-facility adjustment. The code is excluded from the physician fee schedule.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 81215 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist